Taka-Diastase 

Order now: dominika@ksiazkiwnauce.pl

Lysinoalanine · 2 HCl (diastereomeric mixture: LL + LD)

F-1195.0250 Bachem 250.0mg 1371.6 EUR
Description: Sum Formula: C9H19N3O4·2HCl; CAS# [4418-81-9]

2-Di-1-ASP

HY-135009 MedChemExpress 10mM/1mL 135.6 EUR

4-(4-(Dimethylamino)-styryl)-N-methylpyridinium iodide (4-Di-1-ASP)

70006 Biotium 500MG 163.2 EUR
Description: Minimum order quantity: 1 unit of 500MG

Tak-438

abx188897-1g Abbexa 1 g 1813.2 EUR

TAK-901

B1945-25 Biovision each 1005.6 EUR

TAK-901

B1945-5 Biovision each 301.2 EUR

TAK-700

B2209-5 Biovision each 248.4 EUR

TAK-593

B3268-10 ApexBio 10 mg 602.4 EUR
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system.

TAK-593

B3268-100 ApexBio 100 mg 2666.4 EUR
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system.

TAK-593

B3268-5 ApexBio 5 mg 385.2 EUR
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system.

TAK-593

B3268-5.1 ApexBio 10 mM (in 1mL DMSO) 417.6 EUR
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system.

TAK-593

B3268-50 ApexBio 50 mg 1752 EUR
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system.

TAK-715

B1701-25 Biovision each 757.2 EUR

TAK-715

B1701-5 Biovision each 235.2 EUR

TAK-733

B1621-10 ApexBio 10 mg 373.2 EUR
Description: TAK-733 is a potent, ATP-noncompetitive and selective inhibitor of MEK allosteric site with the IC50 value of 3.2nM [1].

TAK-733

B1621-5 ApexBio 5 mg 226.8 EUR
Description: TAK-733 is a potent, ATP-noncompetitive and selective inhibitor of MEK allosteric site with the IC50 value of 3.2nM [1].

TAK-733

B1621-5.1 ApexBio 10 mM (in 1mL DMSO) 234 EUR
Description: TAK-733 is a potent, ATP-noncompetitive and selective inhibitor of MEK allosteric site with the IC50 value of 3.2nM [1].

TAK-733

B1621-50 ApexBio 50 mg 1005.6 EUR
Description: TAK-733 is a potent, ATP-noncompetitive and selective inhibitor of MEK allosteric site with the IC50 value of 3.2nM [1].

TAK960

B5860-10 ApexBio 10 mg 303.6 EUR
Description: Description:IC50: 8.4 to 46.9 nmol/L for multiple cancer cell linesPolo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key mitosis processes.

TAK960

B5860-5 ApexBio 5 mg 226.8 EUR
Description: Description:IC50: 8.4 to 46.9 nmol/L for multiple cancer cell linesPolo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key mitosis processes.

TAK960

B5860-5.1 ApexBio 10 mM (in 1mL DMSO) 282 EUR
Description: Description:IC50: 8.4 to 46.9 nmol/L for multiple cancer cell linesPolo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key mitosis processes.

TAK960

B5860-50 ApexBio 50 mg 811.2 EUR
Description: Description:IC50: 8.4 to 46.9 nmol/L for multiple cancer cell linesPolo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key mitosis processes.

TAK-733

2460-25 Biovision each 966 EUR

TAK-733

2460-5 Biovision each 288 EUR

TAK-632

2473-25 Biovision each 692.4 EUR

TAK-632

2473-5 Biovision each 222 EUR

TAK-242

A3850-10 ApexBio 10 mg 309.6 EUR
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1].

TAK-242

A3850-100 ApexBio 100 mg 1730.4 EUR
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1].

TAK-242

A3850-5 ApexBio 5 mg 226.8 EUR
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1].

TAK-242

A3850-5.1 ApexBio 10 mM (in 1mL DMSO) 243.6 EUR
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1].

TAK-242

A3850-50 ApexBio 50 mg 1034.4 EUR
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1].

TAK-901

A4124-10 ApexBio 10 mg 324 EUR
Description: IC50: 0.0017, 0.021 for Aurora-B/INCENP and Aurora-A/TPX2, respectivelyProtein kinases Aurora A, B, and C play crucial roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention.

TAK-901

A4124-200 ApexBio 200 mg 2133.6 EUR
Description: IC50: 0.0017, 0.021 for Aurora-B/INCENP and Aurora-A/TPX2, respectivelyProtein kinases Aurora A, B, and C play crucial roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention.

TAK-901

A4124-5 ApexBio 5 mg 212.4 EUR
Description: IC50: 0.0017, 0.021 for Aurora-B/INCENP and Aurora-A/TPX2, respectivelyProtein kinases Aurora A, B, and C play crucial roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention.

TAK-901

A4124-5.1 ApexBio 10 mM (in 1mL DMSO) 226.8 EUR
Description: IC50: 0.0017, 0.021 for Aurora-B/INCENP and Aurora-A/TPX2, respectivelyProtein kinases Aurora A, B, and C play crucial roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention.

TAK-901

A4124-50 ApexBio 50 mg 880.8 EUR
Description: IC50: 0.0017, 0.021 for Aurora-B/INCENP and Aurora-A/TPX2, respectivelyProtein kinases Aurora A, B, and C play crucial roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention.

TAK-438

A2308-100 ApexBio 100 mg 2008.8 EUR
Description: TAK-438 is a potassium-competitive acid blocker (P-CAB) that reversibly inhibits gastric H+, K+-ATPase, [1] [2] with ID50 values of 0.86 mg/kg to histamine-stimulated acid secretion in anesthetized rats [1].

TAK-438

A2308-25 ApexBio 25 mg 895.2 EUR
Description: TAK-438 is a potassium-competitive acid blocker (P-CAB) that reversibly inhibits gastric H+, K+-ATPase, [1] [2] with ID50 values of 0.86 mg/kg to histamine-stimulated acid secretion in anesthetized rats [1].

TAK-438

A2308-5 ApexBio 5 mg 338.4 EUR
Description: TAK-438 is a potassium-competitive acid blocker (P-CAB) that reversibly inhibits gastric H+, K+-ATPase, [1] [2] with ID50 values of 0.86 mg/kg to histamine-stimulated acid secretion in anesthetized rats [1].

TAK-438

A2308-5.1 ApexBio 10 mM (in 1mL DMSO) 474 EUR
Description: TAK-438 is a potassium-competitive acid blocker (P-CAB) that reversibly inhibits gastric H+, K+-ATPase, [1] [2] with ID50 values of 0.86 mg/kg to histamine-stimulated acid secretion in anesthetized rats [1].

TAK-285

A8528-10 ApexBio 10 mg 517.2 EUR
Description: TAK-285 is a potent inhibitor of HER2 and EGFR with IC50 value of 17 nM and 23 nM, respectively [1].EGFR (epidermal growth factor receptor) and HER2 are members of ErbB family of receptors and play an important role in stimulating its intrinsic intracellular protein-tyrosine kinase activity.

TAK-285

A8528-5 ApexBio 5 mg 321.6 EUR
Description: TAK-285 is a potent inhibitor of HER2 and EGFR with IC50 value of 17 nM and 23 nM, respectively [1].EGFR (epidermal growth factor receptor) and HER2 are members of ErbB family of receptors and play an important role in stimulating its intrinsic intracellular protein-tyrosine kinase activity.

TAK-285

A8528-5.1 ApexBio 10 mM (in 1mL DMSO) 428.4 EUR
Description: TAK-285 is a potent inhibitor of HER2 and EGFR with IC50 value of 17 nM and 23 nM, respectively [1].EGFR (epidermal growth factor receptor) and HER2 are members of ErbB family of receptors and play an important role in stimulating its intrinsic intracellular protein-tyrosine kinase activity.

TAK-715

A8688-10 ApexBio 10 mg 205.2 EUR
Description: TAK-715 is a selective inhibitor of p38 MAPK with IC50 value of 7.1 nM [1].p38 mitogen-activated protein (MAP) kinases (p38 MAPKs) are a class of mitogen-activated protein kinases and play an important role in controlling cellular responses to cytokines and stress.

TAK-715

A8688-50 ApexBio 50 mg 517.2 EUR
Description: TAK-715 is a selective inhibitor of p38 MAPK with IC50 value of 7.1 nM [1].p38 mitogen-activated protein (MAP) kinases (p38 MAPKs) are a class of mitogen-activated protein kinases and play an important role in controlling cellular responses to cytokines and stress.

TAK-632

A8226-10 ApexBio 10 mg 212.4 EUR
Description: TAK-632 is a selective inhibitor of BRAF, CRAF and BRAF-V600E kinase with IC50 value of 8.3 nM, 1.4 nM and 2.4 nM [1].

TAK-632

A8226-100 ApexBio 100 mg 706.8 EUR
Description: TAK-632 is a selective inhibitor of BRAF, CRAF and BRAF-V600E kinase with IC50 value of 8.3 nM, 1.4 nM and 2.4 nM [1].

TAK-632

A8226-5 ApexBio 5 mg 157.2 EUR
Description: TAK-632 is a selective inhibitor of BRAF, CRAF and BRAF-V600E kinase with IC50 value of 8.3 nM, 1.4 nM and 2.4 nM [1].

TAK-632

A8226-5.1 ApexBio 10 mM (in 1mL DMSO) 177.6 EUR
Description: TAK-632 is a selective inhibitor of BRAF, CRAF and BRAF-V600E kinase with IC50 value of 8.3 nM, 1.4 nM and 2.4 nM [1].

TAK-632

A8226-50 ApexBio 50 mg 477.6 EUR
Description: TAK-632 is a selective inhibitor of BRAF, CRAF and BRAF-V600E kinase with IC50 value of 8.3 nM, 1.4 nM and 2.4 nM [1].

TAK-632

A8226-S ApexBio Evaluation Sample 97.2 EUR
Description: TAK-632 is a selective inhibitor of BRAF, CRAF and BRAF-V600E kinase with IC50 value of 8.3 nM, 1.4 nM and 2.4 nM [1].

TAK-875

A8339-10 ApexBio 10 mg 366 EUR
Description: TAK-875 is a potent, selective, and oral GPR40 agonist. GPR40 is one of the G protein-coupled receptors predominantly expressed in pancreatic ?-cells, mediating enhancement of glucose-stimulated insulin secretion by free fatty acids.

TAK-875

A8339-5 ApexBio 5 mg 226.8 EUR
Description: TAK-875 is a potent, selective, and oral GPR40 agonist. GPR40 is one of the G protein-coupled receptors predominantly expressed in pancreatic ?-cells, mediating enhancement of glucose-stimulated insulin secretion by free fatty acids.

TAK-875

A8339-5.1 ApexBio 10 mM (in 1mL DMSO) 268.8 EUR
Description: TAK-875 is a potent, selective, and oral GPR40 agonist. GPR40 is one of the G protein-coupled receptors predominantly expressed in pancreatic ?-cells, mediating enhancement of glucose-stimulated insulin secretion by free fatty acids.

TAK-875

A8339-50 ApexBio 50 mg 714 EUR
Description: TAK-875 is a potent, selective, and oral GPR40 agonist. GPR40 is one of the G protein-coupled receptors predominantly expressed in pancreatic ?-cells, mediating enhancement of glucose-stimulated insulin secretion by free fatty acids.

Taka-Diastase